据称有110位病人参与了基于被撤销论文的临床实验：
https://www.genomeweb.com//node/959264?hq_e=el&hq_m=904977&hq_l=1&hq_v=55b294d4b1
相关背景：
最新一期Nature Medicine撤销美国杜克大学肿瘤学家的一篇文章“Genomic signatures to guide the use of chemotherapeutics”。
https://www.nature.com/nm/journal/v17/n1/full/nm0111-135.html
文 中提到撤销的原因是“We wish to retract this article because we have been unable to reproduce certain crucial experiments showing validation of signatures for predicting response to chemotherapies, including docetaxel and topotecan”
原帖：
